| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/27/1995 | EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists |
| 09/27/1995 | EP0673257A1 Low toxicity interleukin-2 analogues for use in immunotherapy |
| 09/27/1995 | EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/1995 | EP0462189B1 Combination therapy for treatment of estrogen sensitive diseases |
| 09/27/1995 | EP0455769B1 Use of 7-oh-1,2-benzopyrone for the manufacture of a medicament for the treatment of malignant tumours in humans |
| 09/27/1995 | EP0261225B1 Lectin complex and method and probe for making same |
| 09/27/1995 | CN1108955A The use of compositions for combating tumour diseases |
| 09/27/1995 | CN1108944A Microbiological medicine containing rich selenium for health-care and therapy and its preparation |
| 09/27/1995 | CN1108931A Rapamycin formulations for oral administration |
| 09/26/1995 | US5453520 Baccatine III derivatives |
| 09/26/1995 | US5453497 Process for producing N4 -acyl-5'-deoxy-5-fluorocytidine compounds |
| 09/26/1995 | US5453489 Specific amino acid sequences; bind directly to fibronectin, reduces matrix assembly without affecting binding to cells; antitumor/wound healing agents |
| 09/26/1995 | US5453361 Method for producing biologically active human brain derived neurotrophic factor |
| 09/26/1995 | US5453272 Serine-proline-tyrosine-glycine-arginine-cysteine hexapeptide; immunosuppressant |
| 09/21/1995 | WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b) |
| 09/21/1995 | WO1995025167A1 Anti-egfr single-chain fvs and anti-egfr antibodies |
| 09/21/1995 | WO1995025128A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
| 09/21/1995 | WO1995025125A1 Dna encoding cai resistance proteins and uses thereof |
| 09/21/1995 | WO1995025121A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 09/21/1995 | WO1995025093A1 Acridone-derived bisintercalators as chemotherapeutic agents |
| 09/21/1995 | WO1995025092A1 Inhibitors of farnesyl-protein transferase |
| 09/21/1995 | WO1995025086A1 Isoprenyl transferase inhibitors |
| 09/21/1995 | WO1995024927A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 09/21/1995 | WO1995024924A1 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING α-GALACTOSYL EPITOPES |
| 09/21/1995 | WO1995024915A1 Product and process for regulating signal transduction pathways |
| 09/21/1995 | WO1995024914A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
| 09/21/1995 | WO1995024910A1 Immunotherapy of cancer with allogeneic lymphocytes |
| 09/21/1995 | WO1995024895A1 Uses of perillyl alcohol and perillic acid methyl ester |
| 09/21/1995 | CA2185663A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
| 09/21/1995 | CA2185553A1 Inhibitors of farnesyl-protein transferase |
| 09/21/1995 | CA2185441A1 Isoprenyl transferase inhibitors |
| 09/21/1995 | CA2185433A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 09/21/1995 | CA2185341A1 Dna encoding cai resistance proteins and uses thereof |
| 09/21/1995 | CA2185326A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
| 09/21/1995 | CA2184631A1 Product and process for regulating signal transduction pathways |
| 09/21/1995 | CA2184352A1 Immunotherapy of cancer with allogeneic lymphocytes |
| 09/21/1995 | CA2184269A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 09/20/1995 | EP0672686A1 Ganglioside gm3 derivative having fluorinated ceramide moiety |
| 09/20/1995 | EP0672681A1 Novel antitumor peptide |
| 09/20/1995 | EP0672662A1 Quinoxaline derivative used in the treatment of tumours |
| 09/20/1995 | EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 09/20/1995 | EP0672193A1 Oligonucleotides having a conserved g 4? core sequence |
| 09/20/1995 | EP0672180A1 Oligonucleotide modulation of protein kinase c |
| 09/20/1995 | EP0672151A1 Inhibitors of ced-3 and related proteins |
| 09/20/1995 | EP0672144A1 Interleukin-6 receptor antagonists |
| 09/20/1995 | EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 09/20/1995 | EP0672137A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 09/20/1995 | EP0672130A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 09/20/1995 | EP0672128A1 Stem cell proliferation factor |
| 09/20/1995 | EP0672119A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 09/20/1995 | EP0672042A1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 09/20/1995 | EP0672041A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
| 09/20/1995 | EP0672040A1 Further pyrimidine derivatives and their preparation |
| 09/20/1995 | EP0672036A1 Pharmaceutically active diketopiperazines |
| 09/20/1995 | EP0671952A1 Method for nonspecific cellular immune stimulation |
| 09/20/1995 | EP0671950A1 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies |
| 09/20/1995 | EP0671939A1 Treatment of dermatological malignancies with biologically active peptides |
| 09/20/1995 | EP0671933A1 Novel uses of il-10 |
| 09/20/1995 | EP0671925A1 Therapeutic compounds derived from the neem tree |
| 09/20/1995 | EP0671917A1 Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives |
| 09/20/1995 | EP0671916A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
| 09/20/1995 | EP0671912A1 Injectable taxane derivative based compositions |
| 09/20/1995 | EP0671911A1 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 09/20/1995 | EP0671909A1 Syndecan stimulation of cellular differentiation |
| 09/20/1995 | EP0468012B1 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| 09/20/1995 | CN1108694A 一种淡紫灰叶链霉菌dkrs菌株及用它制备阿克拉希霉素a，b，y和糖苷配基的方法 A lilac gray leaf dkrs Streptomyces strains and its preparation method Rashid Akbar ADM a, b, y and aglycone |
| 09/20/1995 | CN1108653A 2-debenzoyl-2-acyl taxol deriatives and methods for making same |
| 09/20/1995 | CN1108543A "Houjiling"-medicine made from plum and apricot for curing throat disease and production method thereof |
| 09/20/1995 | CN1108529A Rapamycin formulations for oral administration |
| 09/19/1995 | US5451605 Treating skin disorders |
| 09/19/1995 | US5451576 Tumor imaging and treatment by water soluble texaphyrin metal complexes |
| 09/14/1995 | WO1995024490A1 Cell surface protein and effector cell bonding reagent |
| 09/14/1995 | WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
| 09/14/1995 | WO1995024485A2 Coordinate in vivo gene expression |
| 09/14/1995 | WO1995024481A2 Humanized monoclonal antibodies against human interleukin-4 |
| 09/14/1995 | WO1995024473A1 Vascular endothelial growth factor 2 |
| 09/14/1995 | WO1995024466A1 Transforming growth factor alpha h1 |
| 09/14/1995 | WO1995024437A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 09/14/1995 | WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 09/14/1995 | WO1995024414A1 Fibroblast growth factor-10 |
| 09/14/1995 | WO1995024402A1 9-deoxotaxane compounds |
| 09/14/1995 | WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release |
| 09/14/1995 | WO1995024395A1 Quinoline derivatives as immunomodulators |
| 09/14/1995 | WO1995024389A1 Indole derivatives as cck receptor antagonists |
| 09/14/1995 | WO1995024379A1 Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors |
| 09/14/1995 | WO1995024217A1 Methods for modulating t cell unresponsiveness |
| 09/14/1995 | WO1995024213A1 Method of stimulating hematopoiesis with hemoglobin |
| 09/14/1995 | WO1995024209A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 09/14/1995 | WO1995024208A1 Glioblastoma-derived angiogenesis inhibiting factor |
| 09/14/1995 | WO1995024187A1 Plaster-shaped transdermal system with a tamoxifen derivative |
| 09/14/1995 | WO1995024182A1 Human osteoclast-derived cathepsin |
| 09/14/1995 | WO1995003406A3 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 09/14/1995 | CA2443236A1 Human osteoclast-derived cathepsin |
| 09/14/1995 | CA2414016A1 Vascular endothelial growth factor 2 |
| 09/14/1995 | CA2350941A1 Benzamide analogues as parp dna repair enzyme inhibitors |
| 09/14/1995 | CA2214521A1 Quinoline derivatives as immunomodulators |
| 09/14/1995 | CA2185229A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 09/14/1995 | CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
| 09/14/1995 | CA2185027A1 Methods for modulating t cell unresponsiveness |
| 09/14/1995 | CA2185016A1 Transdermal system in the form of a patch comprising a tamoxifen derivative |